Fonar PE Ratio 2010-2025 | FONR
Current and historical p/e ratio for Fonar (FONR) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Fonar PE ratio as of July 15, 2025 is 13.05.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Fonar PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-15 | 16.00 | 12.80 | |
| 2025-03-31 | 14.01 | $1.25 | 11.21 |
| 2024-12-31 | 15.14 | $1.15 | 13.17 |
| 2024-09-30 | 16.19 | $1.40 | 11.56 |
| 2024-06-30 | 16.00 | $1.53 | 10.46 |
| 2024-03-31 | 21.36 | $1.56 | 13.69 |
| 2023-12-31 | 19.56 | $1.84 | 10.63 |
| 2023-09-30 | 15.40 | $1.62 | 9.51 |
| 2023-06-30 | 17.10 | $1.32 | 12.95 |
| 2023-03-31 | 16.20 | $1.16 | 13.97 |
| 2022-12-31 | 16.75 | $0.93 | 18.01 |
| 2022-09-30 | 14.15 | $1.18 | 11.99 |
| 2022-06-30 | 15.19 | $1.44 | 10.55 |
| 2022-03-31 | 18.55 | $1.44 | 12.88 |
| 2021-12-31 | 14.98 | $1.66 | 9.02 |
| 2021-09-30 | 15.46 | $1.53 | 10.10 |
| 2021-06-30 | 17.68 | $1.34 | 13.19 |
| 2021-03-31 | 18.09 | $1.42 | 12.74 |
| 2020-12-31 | 17.36 | $1.06 | 16.38 |
| 2020-09-30 | 20.88 | $1.06 | 19.70 |
| 2020-06-30 | 21.37 | $1.17 | 18.26 |
| 2020-03-31 | 14.62 | $1.75 | 8.35 |
| 2019-12-31 | 19.69 | $2.13 | 9.24 |
| 2019-09-30 | 20.67 | $2.20 | 9.40 |
| 2019-06-30 | 21.51 | $2.21 | 9.73 |
| 2019-03-31 | 20.47 | $2.99 | 6.85 |
| 2018-12-31 | 20.24 | $2.94 | 6.88 |
| 2018-09-30 | 24.90 | $3.04 | 8.19 |
| 2018-06-30 | 26.55 | $3.10 | 8.56 |
| 2018-03-31 | 29.80 | $2.53 | 11.78 |
| 2017-12-31 | 24.35 | $2.90 | 8.40 |
| 2017-09-30 | 30.50 | $2.92 | 10.45 |
| 2017-06-30 | 27.75 | $2.92 | 9.50 |
| 2017-03-31 | 17.55 | $3.01 | 5.83 |
| 2016-12-31 | 19.15 | $2.58 | 7.42 |
| 2016-09-30 | 20.54 | $2.48 | 8.28 |
| 2016-06-30 | 20.36 | $2.37 | 8.59 |
| 2016-03-31 | 15.38 | $2.27 | 6.78 |
| 2015-12-31 | 17.26 | $2.13 | 8.10 |
| 2015-09-30 | 13.41 | $2.00 | 6.71 |
| 2015-06-30 | 10.58 | $1.95 | 5.42 |
| 2015-03-31 | 13.04 | $1.71 | 7.62 |
| 2014-12-31 | 10.40 | $1.66 | 6.27 |
| 2014-09-30 | 11.01 | $1.59 | 6.92 |
| 2014-06-30 | 12.20 | $1.58 | 7.72 |
| 2014-03-31 | 17.58 | $1.70 | 10.34 |
| 2013-12-31 | 21.21 | $1.61 | 13.17 |
| 2013-09-30 | 5.77 | $1.49 | 3.87 |
| 2013-06-30 | 6.56 | $1.34 | 4.90 |
| 2013-03-31 | 6.92 | $0.82 | 8.44 |
| 2012-12-31 | 4.33 | $0.85 | 5.09 |
| 2012-09-30 | 3.75 | $0.88 | 4.26 |
| 2012-06-30 | 4.10 | $0.90 | 4.56 |
| 2012-03-31 | 2.68 | $0.72 | 3.72 |
| 2011-12-31 | 1.70 | $0.72 | 2.37 |
| 2011-09-30 | 1.96 | $0.72 | 2.72 |
| 2011-06-30 | 1.96 | $0.55 | 3.56 |
| 2011-03-31 | 1.68 | $0.52 | 3.23 |
| 2010-12-31 | 1.30 | $0.32 | 4.06 |
| 2010-09-30 | 1.39 | $-0.18 | 0.00 |
| 2010-06-30 | 1.47 | $-0.60 | 0.00 |
| 2010-03-31 | 1.91 | $-0.62 | 0.00 |
| 2009-12-31 | 1.57 | $-0.62 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.101B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.711B | 27.62 |
| Boston Scientific (BSX) | United States | $154.351B | 38.64 |
| Stryker (SYK) | United States | $149.416B | 31.24 |
| EssilorLuxottica (ESLOY) | France | $132.057B | 0.00 |
| Medtronic (MDT) | Ireland | $115.083B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.474B | 25.39 |
| ResMed (RMD) | United States | $37.259B | 27.99 |
| Agilent Technologies (A) | United States | $34.110B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.090B | 16.18 |
| Terumo (TRUMY) | Japan | $24.459B | 31.77 |
| Koninklijke Philips (PHG) | Netherlands | $23.149B | 16.24 |
| Insulet (PODD) | United States | $20.550B | 80.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.570B | 11.93 |
| Baxter (BAX) | United States | $14.641B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.157B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.825B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $5.747B | 14.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Perrigo (PRGO) | Ireland | $3.768B | 9.55 |
| Haemonetics (HAE) | United States | $3.683B | 16.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.395B | 28.21 |
| ICU Medical (ICUI) | United States | $3.220B | 23.75 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.42 |
| LeMaitre Vascular (LMAT) | United States | $1.900B | 42.47 |
| AtriCure (ATRC) | United States | $1.550B | 0.00 |
| Acuren (TIC) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 30.91 |
| Phibro Animal Health (PAHC) | United States | $1.278B | 16.34 |
| AdaptHealth (AHCO) | United States | $1.237B | 12.56 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.053B | 0.00 |
| InMode (INMD) | Israel | $0.932B | 9.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.792B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.749B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.661B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Evolus (EOLS) | United States | $0.613B | 0.00 |
| CeriBell (CBLL) | United States | $0.592B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.449B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.337B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.327B | 12.02 |
| Sanuwave Health (SNWV) | United States | $0.310B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.306B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.33 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.249B | 11.30 |
| Brainsway (BWAY) | Israel | $0.231B | 61.17 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.221B | 6.22 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.00 |
| Vireo Growth (VREOF) | United States | $0.162B | 0.00 |
| Exagen (XGN) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.13 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| Safety Shot (SHOT) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.87 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |